Total Payments
$365,115
2024 Payments
$10,587
Companies
21
Transactions
483
Medicare Patients
11,753
Medicare Billing
$346,741
Payment Breakdown by Category
Other$278,659 (76.3%)
Travel$44,346 (12.1%)
Consulting$30,137 (8.3%)
Food & Beverage$11,928 (3.3%)
Education$45.88 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $269,315 | 126 | 73.8% |
| Travel and Lodging | $44,346 | 150 | 12.1% |
| Consulting Fee | $30,137 | 11 | 8.3% |
| Food and Beverage | $11,928 | 190 | 3.3% |
| Honoraria | $9,344 | 1 | 2.6% |
| Education | $45.88 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $168,818 | 227 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $63,222 | 55 | $0 (2019) |
| Esperion Therapeutics, Inc. | $27,378 | 21 | $0 (2022) |
| Aralez Pharmaceuticals US Inc. | $21,598 | 26 | $0 (2017) |
| Roche Diabetes Care GmbH | $14,865 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $14,153 | 29 | $0 (2019) |
| Amarin Pharma Inc. | $12,674 | 21 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $11,680 | 27 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $10,730 | 20 | $0 (2019) |
| PFIZER INC. | $8,105 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,587 | 23 | Amgen Inc. ($9,895) |
| 2023 | $30,444 | 43 | Amgen Inc. ($30,016) |
| 2022 | $34,413 | 52 | Amgen Inc. ($24,413) |
| 2021 | $26,098 | 29 | Esperion Therapeutics, Inc. ($13,707) |
| 2020 | $25,406 | 30 | Amgen Inc. ($12,579) |
| 2019 | $92,868 | 119 | SANOFI-AVENTIS U.S. LLC ($53,546) |
| 2018 | $49,877 | 73 | Amgen Inc. ($33,911) |
| 2017 | $95,423 | 114 | Amgen Inc. ($27,925) |
All Payment Transactions
483 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $48.78 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Wegovy | Education | In-kind items and services | $8.90 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $665.70 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $131.80 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $156.28 | General |
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Cardiology | ||||||
| 07/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/17/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $117.94 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $93.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Cardiology | ||||||
| 06/11/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $6.91 | General |
| Category: Cardiology | ||||||
| 05/17/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 05/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.74 | General |
| 05/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $129.14 | General |
| Category: Cardiology | ||||||
| 02/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $7.50 | General |
| Category: Cardiology | ||||||
| 01/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Cardiology | ||||||
| 12/29/2023 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $3.93 | General |
| Category: Cardiology | ||||||
| 12/20/2023 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,508 | 5,173 | $438,788 | $80,981 |
| 2022 | 14 | 3,485 | 5,021 | $418,728 | $94,305 |
| 2021 | 14 | 2,813 | 3,576 | $394,266 | $90,327 |
| 2020 | 14 | 1,947 | 2,271 | $346,403 | $81,128 |
Total Patients
11,753
Total Services
16,041
Medicare Billing
$346,741
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,477 | 4,114 | $139,876 | $24,360 | 17.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 490 | 507 | $164,775 | $23,858 | 14.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 117 | 123 | $39,279 | $12,284 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 49 | 49 | $18,139 | $4,224 | 23.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $14,336 | $4,083 | 28.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 62 | 62 | $23,436 | $3,818 | 16.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 30 | 30 | $12,840 | $2,386 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 32 | $7,520 | $2,016 | 26.8% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2023 | 21 | 22 | $5,236 | $1,054 | 20.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 13 | $2,080 | $807.30 | 38.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 54 | 54 | $4,374 | $713.98 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,400 | $609.76 | 25.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 15 | 15 | $1,599 | $288.75 | 18.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 33 | 34 | $1,156 | $203.52 | 17.6% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 17 | 18 | $894.00 | $154.19 | 17.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 53 | 53 | $848.00 | $120.56 | 14.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 561 | 593 | $141,134 | $30,562 | 21.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 2,390 | 3,849 | $130,866 | $23,496 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 152 | 179 | $56,887 | $17,368 | 30.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $16,128 | $5,510 | 34.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2022 | 60 | 61 | $19,459 | $3,641 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 38 | 38 | $13,868 | $3,576 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 52 | $12,580 | $3,326 | 26.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 25 | 26 | $11,128 | $2,203 | 19.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 18 | $4,158 | $1,379 | 33.2% |
About Dr. Carl Lavie, MD
Dr. Carl Lavie, MD is a Cardiovascular Disease healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891744256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Lavie, MD has received a total of $365,115 in payments from pharmaceutical and medical device companies, with $10,587 received in 2024. These payments were reported across 483 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($269,315).
As a Medicare-enrolled provider, Lavie has provided services to 11,753 Medicare beneficiaries, totaling 16,041 services with total Medicare billing of $346,741. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location New Orleans, LA
- Active Since 05/10/2006
- Last Updated 02/10/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1891744256
Products in Payments
- Repatha (Biological) $168,781
- PRALUENT (Drug) $58,104
- NEXLIZET (Drug) $27,378
- DC ACCU-CHEK Diabetes Management Solutions, Cables, Software, Kits and Accessories (Device) $14,865
- ELIQUIS (Drug) $13,716
- Vascepa (Drug) $12,674
- PRALUENT (Biological) $12,481
- PRALUENT ALIROCUMAB INJECTION (Biological) $12,320
- FARXIGA (Drug) $11,381
- ZONTIVITY (Drug) $10,959
- YOSPRALA (Drug) $10,638
- MULTAQ (Drug) $5,118
- LEQVIO (Drug) $4,436
- LifeVest (Device) $557.59
- GALLANT (Device) $207.80
- HeartMate (Device) $166.36
- S-ICD System Magnet (Device) $123.00
- Acticor 7 VR-T DX (Device) $108.72
- MICRA (Device) $85.15
- Assure WCD (Device) $73.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New Orleans
Rajan Patel, M.d, M.D
Cardiovascular Disease — Payments: $545,798
Cardiovascular Disease $545,798
Clement Eiswirth, Md, MD
Cardiovascular Disease — Payments: $362,313
Cardiovascular Disease $362,313
James Jenkins, Md, MD
Cardiovascular Disease — Payments: $319,286
Cardiovascular Disease $319,286
Sammy Khatib, M.d, M.D
Cardiovascular Disease — Payments: $168,538
Cardiovascular Disease $168,538
Stephen Ramee, Md, MD
Cardiovascular Disease — Payments: $80,095
Cardiovascular Disease $80,095
Dr. Jose Wiley, Md, MD
Cardiovascular Disease — Payments: $58,535
Cardiovascular Disease $58,535